With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
Health financing and payment, results-based financing, social protection, conditional cash transfer programs, noncommunicable disease, maternal and child health
Amanda Glassman is chief operating officer and senior fellow at the Center for Global Development and also serves as secretary of the board. Her research focuses on priority-setting, resource allocation and value for money in global health, as well as data for development. Prior to her current position, she served as director for global health policy at the Center from 2010 to 2016, and has more than 25 years of experience working on health and social protection policy and programs in Latin America and elsewhere in the developing world.
Prior to joining CGD, Glassman was principal technical lead for health at the Inter-American Development Bank, where she led policy dialogue with member countries, designed the results-based grant program Salud Mesoamerica 2015 and served as team leader for conditional cash transfer programs such as Mexico’s Oportunidades and Colombia’s Familias en Accion. From 2005-2007, Glassman was deputy director of the Global Health Financing Initiative at Brookings and carried out policy research on aid effectiveness and domestic financing issues in the health sector in low-income countries. Before joining the Brookings Institution, Glassman designed, supervised and evaluated health and social protection loans at the Inter-American Development Bank and worked as a Population Reference Bureau Fellow at the US Agency for International Development. Glassman holds a MSc from the Harvard School of Public Health and a BA from Brown University, has published on a wide range of health and social protection finance and policy topics, and is editor and coauthor of the books Millions Saved: New Cases of Proven Success in Global Health (Center for Global Development 2016), From Few to Many: A Decade of Health Insurance Expansion in Colombia (IDB and Brookings 2010), and The Health of Women in Latin America and the Caribbean (World Bank 2001).
Many low- and middle-income countries aspire to universal health coverage (UHC), but for rhetoric to become reality, the health services offered must be consistent with the funds available, which may require tough tradeoffs. An explicit health benefits package—a defined list of services that are and are not subsidized—is essential in creating a sustainable UHC system.
A new contribution from the Center for Global Development and the International Decision Support Initiative (iDSI)—What’s In, What’s Out: Designing Benefits for Universal Health Coverage, edited by Amanda Glassman, Ursula Giedion and Peter Smith—argues that an explicit health benefits package (HBP), to be funded with public monies, is an essential element of a sustainable and effective health system, and considers the institutional, fiscal, methodological, legal, and ethical dimensions of their design and implementation. This event—a private policy breakfast and release of the book—aims to gather leading voices for universal health coverage, effective health financing, and evidence-based health policy to discuss and debate the book’s key findings and messages. Hard copies of the book will be available for all attendees.
Earlier this month, the first analysis of countries’ progress towards attaining the health-related Sustainable Development Goals (SDGs) was published in the Lancet. The Institute for Health Metrics and Evaluation (IHME) used Global Burden of Disease Data (GBD 2016) to create an index for 37 (out of 50) health-related SDG indicators between 1990–2016, for a total of 188 countries. Based on the pace of change recorded over the past 25 years or so, the researchers then projected the indicators to 2030. The punchline: if past is prologue, the median number of SDG targets attained in 2030 will be five of the 24 defined targets currently measured. Not very inspiring.
In recent years, there has been tremendous progress in improving the treatment and prevention of diseases, resulting in millions of lives saved around the world. While some of this progress is due to economic growth, aid from several bilateral, multilateral, and philanthropic donors has made important contributions to reducing the global burden of disease. In this seminar, Alec Morton will present new research focusing on decision rules to guide how donors should allocate aid money given that resources are limited.
Global health policy enthusiasts will be excited to see that WHO has recently published a draft Concept Note on the 2019-2023 Programme of Work under the stewardship of its new Director-General. We see two glaring missed opportunities: 1) more centrality to universal health coverage (UHC) as an organizing principle for WHO and its work, and 2) more emphasis on enhancing the value for money of public spending on UHC and elsewhere.
Clear and rigorous evidence on the contributions of US global health programs is more important than ever, as the White House and lawmakers discuss and debate budgets and the future of US support to global health. Such information aids policymakers who must prioritize support to effective public health programs.
In low- and middle-income countries, a hospital is often the first stop for citizens that experience illness, or the last stop when their health needs aren’t met by primary care. And as countries grow economically, the demand for quality health services at all levels will grow.
In this essay, Toby Ord explores the moral relevance of cost-effectiveness, a major tool for capturing the relationship between resources and outcomes, by illustrating what is lost in moral terms for global health when cost-effectiveness is ignored.
Consumption taxes for goods and services—sometimes called Value Added Taxes or VAT—are a common and effective revenue-raising tool used in many developing countries. But in some low- and middle-income countries, all but the poorest 10% of the population pay more in such taxes than they receive in cash transfers—even to the extent of worsening poverty levels. This has occurred in countries as varied as Armenia, Bolivia, Brazil, Colombia, Ethiopia and Sri Lanka. Lustig will draw on new research from the Commitment to Equity (CEQ) project to show how replacing external aid with domestic resources generated through consumption taxes could have onerous consequences for the poor.
Lustig directs the Commitment to Equity (CEQ), a partnership with Tulane University, the Inter-American Dialogue, and CGD. The CEQ offers research and analysis on the equity impact of taxes and transfers in an effort to support governments, multilateral institutions, and nongovernmental organizations in their efforts to build more equitable societies.
In 2016 on the CGD Podcast, we have discussed some of development's biggest questions: How do we pay for development? How do we measure the sustainable development goals (SDGs)? What should we do about refugees and migrants? And is there life yet in the notion of globalism? The links to all the full podcasts featured and the work they reference are below, but in this edition, we bring you highlights of some of those conversations.
Human capital and its relation to poverty are central areas of study in development economics. The Mexican conditional cash transfer (CCT) program Progresa/Oportunidades is a particularly innovative human capital development program that was rigorously evaluated using a randomized design. In a time when randomized evaluations of social policy were still rare, a large-scale randomized evaluation was carried out that demonstrated important effects of the program on human capital accumulation and on poverty alleviation.
The program’s novelty and the finding of positive initial impacts contributed to both a large scaling up within Mexico and an impressive spreading of the program’s key features to new programs around the world. Susan Parker will review the academic literature on the development, evaluation and findings of the Progresa/Oportunidades program from her work with co-author Petra E. Todd.
In this paper, the authors discuss the rationale for
investing in vaccination and construct a
metric to measure country commitment
to vaccination that would promote
accountability and better tracking of